WHY SPONSOR?

CROs

Introduce your dedicated clinical trial solutions to advance the work in orphan drug and rare disease research and development

Market Access Consultants

Present your innovative market access strategies to orphan drug regulators and licensing authorities across Asia

Regulatory Consultants

Show the industry how policies can evolve to improve the efficacy of licensure and regulatory processes

Specialty Pharma Distributors

Demonstrate your capability as a specialised distributor in the industry and share the importance of enhancing these distribution networks

Software solutions

Whether it be for streamlined connections with patients, or for aggregating scientific data, the orphan drug and rare disease sector can benefit from this.

Medical communications experts

Because articulating the value of orphan drugs requires meticulous work, and is industry’s best bet in helping government understand the need of orphan drugs